JP2023508250A5 - - Google Patents

Info

Publication number
JP2023508250A5
JP2023508250A5 JP2022564096A JP2022564096A JP2023508250A5 JP 2023508250 A5 JP2023508250 A5 JP 2023508250A5 JP 2022564096 A JP2022564096 A JP 2022564096A JP 2022564096 A JP2022564096 A JP 2022564096A JP 2023508250 A5 JP2023508250 A5 JP 2023508250A5
Authority
JP
Japan
Prior art keywords
ghrelin
mtbi
variant
patient
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022564096A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023508250A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/066703 external-priority patent/WO2021133844A1/en
Publication of JP2023508250A publication Critical patent/JP2023508250A/ja
Publication of JP2023508250A5 publication Critical patent/JP2023508250A5/ja
Pending legal-status Critical Current

Links

JP2022564096A 2019-12-23 2020-12-22 軽度外傷性脳損傷の処置 Pending JP2023508250A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962953130P 2019-12-23 2019-12-23
US62/953,130 2019-12-23
PCT/US2020/066703 WO2021133844A1 (en) 2019-12-23 2020-12-22 Treatment of mild traumatic brain injury

Publications (2)

Publication Number Publication Date
JP2023508250A JP2023508250A (ja) 2023-03-01
JP2023508250A5 true JP2023508250A5 (cg-RX-API-DMAC10.html) 2024-01-04

Family

ID=76575665

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022564096A Pending JP2023508250A (ja) 2019-12-23 2020-12-22 軽度外傷性脳損傷の処置

Country Status (11)

Country Link
US (1) US20230031262A1 (cg-RX-API-DMAC10.html)
EP (1) EP4081238A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023508250A (cg-RX-API-DMAC10.html)
KR (1) KR20220122691A (cg-RX-API-DMAC10.html)
CN (1) CN114980915A (cg-RX-API-DMAC10.html)
AU (1) AU2020412765A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022012365A2 (cg-RX-API-DMAC10.html)
CA (1) CA3165738A1 (cg-RX-API-DMAC10.html)
IL (1) IL294156A (cg-RX-API-DMAC10.html)
MX (1) MX2022007844A (cg-RX-API-DMAC10.html)
WO (1) WO2021133844A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220370804A1 (en) * 2021-01-22 2022-11-24 The Regents Of The University Of Colorado, A Body Corporate Motor learning and vagus nerve stimulation (vns) paired with motor learning to treat demyelinating diseases, conditions and disorders
CN113723530B (zh) * 2021-09-02 2022-03-25 中国科学院自动化研究所 基于视频分析和电子心理沙盘的智能心理评估系统
US20260077018A1 (en) * 2022-09-07 2026-03-19 Oxeia Biopharmaceuticals, Inc. Treatment of mild traumatic brain injury

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6545697B2 (ja) * 2013-11-15 2019-07-17 ニューラル・アナリティクス・インコーポレーテッド 神経学的状態の診断のための脳の血流速度の構造的特徴をモニタリングすること
US9119832B2 (en) * 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
HK1231413A1 (zh) * 2014-04-29 2017-12-22 Teva Pharmaceutical Industries Ltd. 用於治疗具有高残疾状况的复发-缓解型多发性硬化症(rrms)的患者的拉喹莫德
CA2961889A1 (en) * 2014-08-19 2016-02-25 Oxeia Biopharmaceuticals, Inc. Methods of treating mild brain injury
US20180028617A1 (en) * 2015-02-19 2018-02-01 The Regents Of The University Of California Methods of treating mild brain injury and post-traumatic stress disorder
WO2016144978A1 (en) * 2015-03-09 2016-09-15 Oxeia Biopharmaceuticals, Inc. Methods of treating cognitive impairments or dysfunction
WO2017075535A1 (en) * 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Similar Documents

Publication Publication Date Title
Lipman Analgesic drugs for neuropathic and sympathetically maintained pain
RU2012117563A (ru) Режим дозирования модулятора рецептора s1p
DE202010018377U1 (de) Niedrigfrequente therapie mit glatirameracetat
DE06075704T1 (de) Vorbeugung und Behandlung von amyloidogener Krankheit
CN110974828B (zh) 化合物Axitinib在制备治疗脑血管疾病的药物中的应用及其药物组合物
US20240335502A1 (en) Uses of bremelanotide in therapy for female sexual dysfunction
CN109172550B (zh) 一种复合麻醉药物
Ravi et al. Ocular complications with dental local anaesthesia-a systematic review of literature and case report: clinical review
Schiff Collapse following parenteral administration of solution of thiamine hydrochloride
CN118490762B (zh) 一种防治早泄的外用中药复方组合物
JPH07506333A (ja) 勃起機能不全症治療用ピリジルグアニジン化合物
Evans et al. Nifuratel compared with metronidazole in the treatment of trichomonal vaginitis
Vogt et al. A preoperative retrobulbar block in patients undergoing scleral buckling reduces pain, endogenous stress response, and improves vigilance
Egbu et al. Steroid-induced hiccups in a patient managed for pseudo foster-kennedy syndrome: a case report of good outcome with the use of gabapentin
Cole Ocular complications resulting from intra-arterial injection during inferior alveolar nerve anesthesia
Bowsher et al. Central post-stroke pain: Drug treatment options
Singh et al. Comparisons of tramadol with pethidine for prevention of post anaesthetic shivering in elective abdominal surgery
CN105451749A (zh) 吸附雄蜂幼虫匀浆和维生素d3或d族维生素和/或其活性代谢物在病毒性疾病的预防和治疗中的应用
IL230174A (en) Pharmaceutical composition for the treatment of premature ejaculation
Rosen et al. Surgical anesthesia: When a tool becomes a weapon
RU2746295C1 (ru) Способ обезболивания и седации в стоматологии
OCCURS Managing patients with cluster headache in primary care
Pandey et al. A comparative study of steroid injection with or without lignocaine in treating frozen shoulder
Arangannal et al. Intranasal Local Anaesthesia: A Recent Advancement in Pediatric Dentistry.
US10744174B1 (en) Composition(s) and method(s) for topically treating pain